FDA Approved: MORPHINE SULFATE — Supplemental Application (Fresenius Kabi, USA LLC)

View source ↗

Summary

FDA has approved a supplemental application for Morphine Sulfate submitted by Fresenius Kabi, USA LLC under NDA204223.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain
• Pain
• Postoperative Pain

Drugs mentioned

• MORPHINE SULFATE (MORPHINE SULFATE)

Snippet

SUPPL AP for MORPHINE SULFATE (MORPHINE SULFATE)